Wilmer Cutler Pickering Hale and Dorr advised Astria Therapeutics, Inc., and Cooley advised the underwriters. Astria Therapeutics, Inc. (Astria) (Nasdaq: ATXS) announced it completed its underwritten registered...
Astria Therapeutics’ $125 Million Common Stock Offering
Inozyme Pharma’s Common Stock Public Offering
Wilmer Cutler Pickering Hale and Dorr represented Inozyme Pharma and Shearman & Sterling represented the underwriters in the offering. Inozyme Pharma, Inc. announced the closing of its...
Immuta’s $90M Series D Funding
Wilmer Cutler Pickering Hale and Dorr LLP advised Immuta on the deal. Immuta, the leading provider of cloud data access control, announced that it has secured...
Immuta’s $90M Series D Funding
Wilmer Cutler Pickering Hale and Dorr LLP advised Immuta on the deal. Immuta, the leading provider of cloud data access control, announced that it has secured...